Based on 11 reviews
Lassen Therapeutics is a biotechnology company developing novel, best-in-class biotherapeutics to treat serious diseases. Their lead program targets interleukin-11, a cytokine central to fibrosis, and their lead candidate is LASN01, a monoclonal antibody targeting IL-11 receptor alpha. The company is located at 5510 Morehouse Drive, Suite 100 in San Diego, CA 92121 and focuses on fibrosis, rare diseases, and oncology.
The company recently secured $85 million in Series B financing in December 2023, which was oversubscribed. This funding will support Phase 2 studies for LASN01 in thyroid eye disease and continue development of LASN500 in IND enabling studies. They have also announced the first patient dosed in a Phase 1 trial evaluating LASN01 for thyroid eye disease.
Multiple reviewers consistently praise the staff for being friendly, professional, and knowledgeable. They also highlight the exceptional quality of care and services provided, with many noting that the team goes above and beyond to ensure the best possible outcome for patients.
The company is based in San Diego, California, specifically at 5510 Morehouse Drive, Suite 100. They operate in the United States and focus their research and development on fibrosis, rare diseases, and oncology through their antibody technology platforms.
Lassen Therapeutics collaborates with leading academic and industry partners to advance their medical and scientific knowledge. They emphasize collaboration as a core value and welcome inquiries for partnerships or research ideas that align with their areas of interest in biotherapeutics.
The company's lead candidate, LASN01, is a fully human clinical-stage antibody that binds to IL-11R to potently block IL-11 signaling. This mechanism aims to prevent IL-11 driven fibrotic diseases, offering a potential new therapeutic option for conditions like thyroid eye disease.
The company's pipeline includes LASN500, which is currently undergoing Investigational New Drug (IND) enabling studies. They are also actively developing LASN01 for Phase 2 studies in thyroid eye disease following the successful Phase 1 trial dosing.
The company announced the first patient dosed in a Phase 1 trial evaluating LASN01 in thyroid eye disease in December 2023. This milestone was part of their broader strategy to translate new science into medicines for patients with serious diseases.
The company's website states they are combining innovative science, leading technology, and unmatched know-how to create novel medicines. Their approach involves targeting mechanisms of action with high impact and deploying best-in-class technologies for speed and efficiency.
The company's core values include being innovative and adaptable, honest and transparent, collaborative, focused on people, and passionate about creating life-improving medicines. These values guide their team and interactions with collaborators.
The company presents preclinical data at major scientific meetings, such as the American Thyroid Association 2023 Annual Meeting and the European Respiratory Society (ERS) and European Thyroid Association (ETA) Annual Meetings. They share findings on blocking the IL-11 pathway with LASN01 for thyroid eye disease and idiopathic pulmonary fibrosis.
The company's services are described as exceptional and top-notch by multiple reviewers who found the staff knowledgeable and caring. The quality of care is frequently cited as a key reason for their high satisfaction ratings across various interactions.
The official website of Lassen Therapeutics is lassentherapeutics.com.
AI-generated from reviews on this page. Verify anything important with the company directly.
I recently had the opportunity to use the services of Lassen Therapeutics, and I was very impressed. The staff was professional and attentive, and the quality of care I received was top-notch. I would highly recommend this company to others!
I had a great experience with Lassen Therapeutics. The staff was friendly and professional, and the services provided were exceptional. I would definitely recommend them to others in need of their expertise.
The services provided by Lassen Therapeutics were outstanding. The staff was friendly and professional, and the quality of care I received was exceptional. I highly recommend them to anyone in need of their services.
I had a wonderful experience with this company. The services provided were exceptional, and the staff was friendly and helpful. I would definitely recommend them to anyone in need of their services.
I'm so happy with the services provided by Lassen Therapeutics! The staff is friendly and professional, and the quality of care is exceptional. I will definitely be recommending them to my friends and family.
I recently visited Lassen Therapeutics and I was incredibly impressed. The staff was friendly, professional, and knowledgeable. The services provided exceeded my expectations and I would highly recommend them to anyone in need of their expertise. Keep up the great work!
The services provided by Lassen Therapeutics are truly exceptional. I am extremely satisfied with their expertise and professionalism. The staff is knowledgeable and caring, always going above and beyond to ensure the best possible outcome for their patients. I highly recommend Lassen Therapeutics to anyone seeking top-quality healthcare.
I had a great experience with this company. The services provided were excellent and the staff was friendly and professional. I would definitely recommend them to others in need of their services.
π Lassen Therapeutics is an amazing company! The staff is knowledgeable and friendly, and they provide excellent services. I am really impressed with their expertise and professionalism. Keep up the good work! π
I am extremely impressed with the services provided by Lassen Therapeutics. The staff is knowledgeable and caring, and they go above and beyond to ensure the best possible outcome for their patients. I highly recommend them to anyone in need of top-quality healthcare.
π I can't say enough good things about Lassen Therapeutics! The staff is excellent and the services provided are top-notch. I am extremely satisfied with my experience and would recommend them to anyone in need of their expertise. π
No news yet. This is where the business shares its own updates and press.
No photos yet. Photos shared by reviewers will show up here.
Lassen Therapeutics develops antibodies as potential treatments for fibrosis, rare diseases, and oncology. The companyβs lead candidate is LASN01, a best-in-class monoclonal antibody targeting IL-11 receptor alpha (IL-11R). IL-11, a member of the IL-6 family of cytokines, is a central mediator of fibrosis and blocking its activity has the potential to be more effective than targeting other factors such as TGF-Ξ² and CTGF. IL-11 is also a pivotal effector of tumor microenvironment organization and tumor growth, playing a key role as a mediator between cancer and stromal cells.